Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6538603rdf:typepubmed:Citationlld:pubmed
pubmed-article:6538603lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6538603lifeskim:mentionsumls-concept:C0007138lld:lifeskim
pubmed-article:6538603lifeskim:mentionsumls-concept:C0600139lld:lifeskim
pubmed-article:6538603lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:6538603lifeskim:mentionsumls-concept:C0010583lld:lifeskim
pubmed-article:6538603lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:6538603lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:6538603lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:6538603lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:6538603pubmed:issue5lld:pubmed
pubmed-article:6538603pubmed:dateCreated1984-5-17lld:pubmed
pubmed-article:6538603pubmed:abstractTextWe observed a remarkable clinical response to cisplatinum and cyclophosphamide in a patient with widespread metastatic transitional cell cancer of the prostate after hormonal therapy proved ineffective. Combination chemotherapy has the potential for an impressive response in these patients.lld:pubmed
pubmed-article:6538603pubmed:languageenglld:pubmed
pubmed-article:6538603pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6538603pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6538603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6538603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6538603pubmed:statusMEDLINElld:pubmed
pubmed-article:6538603pubmed:monthMaylld:pubmed
pubmed-article:6538603pubmed:issn0022-5347lld:pubmed
pubmed-article:6538603pubmed:authorpubmed-author:LeeS SSSlld:pubmed
pubmed-article:6538603pubmed:authorpubmed-author:AlexanderS...lld:pubmed
pubmed-article:6538603pubmed:authorpubmed-author:BekhradAAlld:pubmed
pubmed-article:6538603pubmed:issnTypePrintlld:pubmed
pubmed-article:6538603pubmed:volume131lld:pubmed
pubmed-article:6538603pubmed:ownerNLMlld:pubmed
pubmed-article:6538603pubmed:authorsCompleteYlld:pubmed
pubmed-article:6538603pubmed:pagination975-7lld:pubmed
pubmed-article:6538603pubmed:dateRevised2006-4-24lld:pubmed
pubmed-article:6538603pubmed:meshHeadingpubmed-meshheading:6538603-...lld:pubmed
pubmed-article:6538603pubmed:meshHeadingpubmed-meshheading:6538603-...lld:pubmed
pubmed-article:6538603pubmed:meshHeadingpubmed-meshheading:6538603-...lld:pubmed
pubmed-article:6538603pubmed:meshHeadingpubmed-meshheading:6538603-...lld:pubmed
pubmed-article:6538603pubmed:meshHeadingpubmed-meshheading:6538603-...lld:pubmed
pubmed-article:6538603pubmed:meshHeadingpubmed-meshheading:6538603-...lld:pubmed
pubmed-article:6538603pubmed:meshHeadingpubmed-meshheading:6538603-...lld:pubmed
pubmed-article:6538603pubmed:meshHeadingpubmed-meshheading:6538603-...lld:pubmed
pubmed-article:6538603pubmed:year1984lld:pubmed
pubmed-article:6538603pubmed:articleTitleTransitional cell carcinoma of the prostate: response to treatment with cisplatinum and cyclophosphamide.lld:pubmed
pubmed-article:6538603pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6538603pubmed:publicationTypeCase Reportslld:pubmed